# OnCo record aryogen-pharmed (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/aryogen-pharmed/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "aryogen-pharmed" ;
  schema:name "AryoGen Pharmed"@en ;
  schema:alternateName "AryoGen"@en, "AryoGen Pharmed Co."@en, "آریوژن فارمد"@en ;
  schema:description "An Iranian company in the CinnaGen group that makes copies of the cancer antibodies trastuzumab, bevacizumab and rituximab for patients in Iran."@en ;
  schema:url <https://onco.cc/companies/aryogen-pharmed/>, <https://www.aryogen.com> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://web.archive.org/web/20250517191056/https://www.aryogen.com/about/>, <https://web.archive.org/web/20260214201350/https://www.aryogen.com/%D9%85%D8%AD%D8%B5%D9%88%D9%84%D8%A7%D8%AA-%D9%85%D8%A7/>, <https://clinicaltrials.gov/study/NCT03288987>, <https://clinicaltrials.gov/study/NCT06021379> ;
  schema:addressCountry "IR" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/biosimilar-manufacturing/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/rituximab/> ;
  onco:companies <https://onco.cc/companies/cinnagen/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:trials <https://onco.cc/trials/nct03288987/>, <https://onco.cc/trials/nct06021379/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-be1040v-bevacizumab-biosimilar-clin-ther-2020/>, <https://onco.cc/key-papers/paper-aryotrust-trastuzumab-pms-2024/> .